Plain-English translation of NCT06994546 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a medication called ArtiBest, which is a gel injection containing hyaluronic acid—a naturally occurring substance that helps lubricate joints. Researchers want to see if this injection can safely reduce knee pain and improve how well your knee works in people with mild to moderate knee arthritis. The study will follow you for six months after you receive the injection to measure how much pain relief and improvement you experience.
Many people with knee arthritis don't get enough relief from pain medications or physical therapy alone. This medication is designed to provide longer-lasting pain relief by improving the cushioning inside the knee joint, and this study will confirm whether it truly works and is safe for everyday use.
You likely qualify if…
You likely don't qualify if…
You will receive a single injection of the gel directly into your knee joint at your first visit. After that, you'll have a phone call from the research doctor at 4 weeks, and then return for in-person follow-up visits at 12 weeks and 26 weeks. During these visits, the doctor will check your pain level, measure how well your knee moves, and may take X-rays to see if the joint has improved. The entire study lasts about 6 months from your injection date.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Taiwan